Literature DB >> 12603184

Adrenal crises in children treated with high-dose inhaled corticosteroids for asthma.

Joseph S Macdessi1, Tabitha L Randell, Kim C Donaghue, Geoffrey R Ambler, Peter P van Asperen, Craig M Mellis.   

Abstract

Three children presented with adrenal crises, manifested by vomiting and hypoglycaemia, after protracted courses of high-dose inhaled corticosteroids for asthma. Significant dose reduction was possible in all three without loss of asthma control, emphasising the importance of back-titration to minimise dose. Parents of children taking high doses of inhaled corticosteroids should be alerted to the clinical features of adrenal insufficiency. If suspected, prompt medical assessment should be arranged, including serum glucose and cortisol measurement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603184     DOI: 10.5694/j.1326-5377.2003.tb05165.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  15 in total

1.  Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma.

Authors:  Priyadarshini Kachroo; Isobel D Stewart; Rachel S Kelly; Meryl Stav; Kevin Mendez; Amber Dahlin; Djøra I Soeteman; Su H Chu; Mengna Huang; Margaret Cote; Hanna M Knihtilä; Kathleen Lee-Sarwar; Michael McGeachie; Alberta Wang; Ann Chen Wu; Yamini Virkud; Pei Zhang; Nicholas J Wareham; Elizabeth W Karlson; Craig E Wheelock; Clary Clish; Scott T Weiss; Claudia Langenberg; Jessica A Lasky-Su
Journal:  Nat Med       Date:  2022-03-21       Impact factor: 87.241

2.  Risk of adverse gastrointestinal events from inhaled corticosteroids.

Authors:  Richard A Hansen; Wanzhu Tu; Jane Wang; Roberta Ambuehl; Clement J McDonald; Michael D Murray
Journal:  Pharmacotherapy       Date:  2008-11       Impact factor: 4.705

Review 3.  Safety of the newer inhaled corticosteroids in childhood asthma.

Authors:  Tabitha L Randell; Kim C Donaghue; Geoffrey R Ambler; Christopher T Cowell; Dominic A Fitzgerald; Peter P van Asperen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression.

Authors:  K A Dunlop; D J Carson; H J Steen; V McGovern; J McNaboe; M D Shields
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

Review 5.  Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects.

Authors:  Camilla Christensson; Anders Thorén; Bengt Lindberg
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.

Authors:  Michael J Perrio; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.

Authors:  Alexandra Ahmet; Harold Kim; Sheldon Spier
Journal:  Allergy Asthma Clin Immunol       Date:  2011-08-25       Impact factor: 3.406

8.  Cough management: a practical approach.

Authors:  Francesco De Blasio; Johann C Virchow; Mario Polverino; Alessandro Zanasi; Panagiotis K Behrakis; Gunsely Kilinç; Rossella Balsamo; Gianluca De Danieli; Luigi Lanata
Journal:  Cough       Date:  2011-10-10

9.  Inhaled corticosteroids for cystic fibrosis.

Authors:  Ian M Balfour-Lynn; Karen Welch; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-07-04

10.  Cough: are children really different to adults?

Authors:  Anne B Chang
Journal:  Cough       Date:  2005-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.